Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?

S Glück

doi:10.1093/annonc/mdr338

Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?

S Glück

Open Access

https://doi.org/10.1093/annonc/mdr338

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2011
License type: publisher-specific-oa

Affiliation: University of Miami

#Cyclophosphamide, Methotrexate, 5-fluorouracil #International Breast Cancer Study Group + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?

Full Text